Feedback Share Discussion Threads

[ged5] 07/10/2021 20:34

Had to look up the significance of green ink. Yump probably knew! :-)

I'm now lost with this company. I just don't know what the future holds. I hear the future is so divine but I'll just wait until I get a sign.

Well Thursday night is my cooking night. Lemon chicken and rice with mushroom and red pepper. Lots of chilli and garlic! And I like to listen to Deep Purple whilst cooking and couldn't help thinking of Feedback. Edit: Why?

Just off to write in green ink!

[lr2] 07/10/2021 19:33

Don't forget to use green ink.

[ducatiman] 07/10/2021 17:44

Nice placing fybberf! 🤔

[ged5] 06/10/2021 15:55

Ha ha!

OT
Whilst watching this space I've also taken a few MAC the past couple of weeks. Maybe worth a look. I liked the small number of shares and low market cap.

Also a very few BHL small lithium play in USA.

[digger2779] 06/10/2021 15:38

Hey Ged - maybe it's a different space to the one we've been watching ie. Tom's wage slip?

[ged5] 06/10/2021 14:39

Nice speech but then someone tweeted;

"I think I speak for most people in saying that we're very impressed with what you've all achieved but, me & the guys and gals have been having a conflab and wanted to know when this might translate into cold hard cash?"

To which FDKMED replied:-

"All we can say is watch this space!"

Well I think we've been watching this space for two effing years and little has happened.

Need a contract or two before we see the cash figures next week maybe.

[ged5] 06/10/2021 14:14

We could continue extending existing digital systems within the NHS, or, explains Dr Tom Oakley, we could fix the problem for good.

We stand, right now, at a crossroads.

One way lies more of the same: expensive, outdated and isolated NHS systems, where the left hand can’t talk to the right, even if it wanted to. The other: lasting, transformational change, that’s at once more efficient and available at a fraction of the cost.

To future-proof the NHS, it’s vital we opt for the latter. And it all starts on the great British high street – specifically, with community diagnostic hubs (CDHs) and the right digital infrastructure to connect the hubs to other local care provider settings.

[digger2779] 06/10/2021 12:25

That's where I've gone wrong all these years.

[yump] 06/10/2021 12:00

Well there are plenty of pointless posts, but yddddrs is on a whole new level.

[ducatiman] 06/10/2021 10:40

You don’t say 😂

[ydderf] 06/10/2021 09:18

LR2,digger2779,ducatiman. For every 'buy' there is a 'sell' the market makers are very unlikely to hold stock or take a position in such an illiquid stock. So in post 8556 for example the reality is that the 'market' is basically operating on a matched bargain basis, and there will always be a matching bargain over time if not immediately. The key variable is the difference between buys and sells at a specific price, the price will tend to fall to the 'clearing level' ie where buyers and sellers and in balance. The price decline over recent weeks has occurred because the seller has exhausted the buyers at each successive price point. Consider, if there is a seller of 1000 shares at .7 and only only one buyer of 900 share at .7, the bid will drop to the next level of demand, e.g. .65

A rational investor will assume that there is a possibility of 1) a huge contract, 2, a modest contract, 3, no commercial contract, 4, a heavily dilutive placing, 5 a modest dilutive placing. An optimist (probably because they are already under water and in denial) will overweight possibility '1' and a pessimist overweight possibility '4'

But nobody including all here, including me and even TO have any idea of that is going to happen, that's why its called the 'future'.

[yump] 05/10/2021 17:19

I think we could all see a year ago or more, that Bleepa could be useful in all sorts of clinical settings, couldn't we ?

I've been in those situations myself. All sorts of people talk to you at exhibitions and say they can see various applications for your product. Everyone leaves feeling enthusiastic.

Unfortunately those people more often than not, are not the entry point into the organisation and every one of them has to be worked hard, to get the lead to that entry point. Especially with large potential customers.

I would hope that TO knows by now the exact points of best approach to sell, given that he's a clinician.

[lr2] 05/10/2021 16:44

Your assumption is correct Duc.

[digger2779] 05/10/2021 16:44

Thanks LR2.
ducatiman - think so as the bid was .702 yesterday and dropped to .7 today.

[ducatiman] 05/10/2021 16:27

I am assuming the .73 trades are buys.

[lr2] 05/10/2021 11:30

Feedback over mogelijkheden voor 'Bleepa'-product

[...]
(Unable to provide link due to Advfn restrictions.)

Gespecialiseerd bedrijf voor medische beeldvormingstechnologie Feedback heeft donderdag de markt bijgewerkt op 'Bleepa' en meldde dat het een aantal potentiële kansen voor het product in overweging nam na de lancering op de NHS Expo in september.

Het AIM-handelsbedrijf zei dat het in "geavanceerde besprekingen" was met NHS-pilotsites, terwijl het daarnaast een aantal commerciële kansen nastreefde binnen en buiten de NHS, en hoopte in de nabije toekomst met Bleepa-pilotprogramma's te beginnen.

Tot op heden was het Bleepa-product "goed ontvangen" door de zorggemeenschap, meldde het bestuur, eraan toevoegend dat het geloofde dat het een aantal zorgverleners in staat zou stellen om "snellere, veiligere, efficiëntere" zorg te bieden.

"We zijn erg bemoedigd door de reactie op het feit dat Bleepa dit heeft besproken met senior NHS-managers en clinici op NHS Expo", zei CEO Tom Oakley.

“De feedback die we hebben ontvangen is dat Bleepa duidelijk toepassingen heeft in de zorgsector, niet alleen in individuele ziekenhuisomgevingen, maar ook in gemeenschaps- en cross-site klinische omgevingen.

"We kijken ernaar uit om te zijner tijd verdere aankondigingen te doen met betrekking tot Bleepa®."
___________________________________________________________________________________________________

Specialist medical imaging technology company Feedback on Thursday updated the market on 'Bleepa' and said it was considering a number of potential opportunities for the product after its launch at the NHS Expo in September.

The AIM trading company said it was in "advanced talks" with NHS pilot sites, while also pursuing a number of commercial opportunities within and outside the NHS, and hoped to begin Bleepa pilot programs in the near future.

To date, the Bleepa product has been "well received" by the healthcare community, the board reported, adding that it believed it would empower some healthcare providers to provide "faster, safer, more efficient" care.

“We are very encouraged by the response to Bleepa discussing this with senior NHS managers and clinicians at NHS Expo,” said CEO Tom Oakley.

“The feedback we have received is that Bleepa clearly has applications in the healthcare sector, not only in individual hospital settings, but also in community and cross-site clinical settings.

"We look forward to making further announcements regarding Bleepa® in due course."

[lr2] 04/10/2021 20:07

1% for Feedback then?

Another $4,000 plus for every man, woman and child in the UK to cough up for this plan.

[ducatiman] 04/10/2021 19:21

Rishi Sunak looks to boost UK economy by $270bn with AI investment

[haroldthegreat] 01/10/2021 11:24

Ydder in my opinion the saving refers to all staff time involved per referral not just the consultant's time .

[ged5] 01/10/2021 09:54

@Bleepame just tweeted:-

Ministers say network of 40 diagnostic clinics in community venues will help tackle growing backlog in NHS treatment #NHS #diagnostics #communitydiagnostics

[ged5] 01/10/2021 09:50

Following the above post, Investor Bill found this:-

[ged5] 01/10/2021 08:39

Just been announced on North West news the launch of one of the biggest NHS trusts in the country, Northern Care Alliance It includes Salford Royal, Fairfield, Rochdale Infirmary and Royal Oldham Hospital.

Perhaps this is a precursor to contracts being signed.

Thanks LR2 for links.

[lr2] 01/10/2021 08:37

Thanks Trevor, the author certainly got that wrong in attempting to summarise the original analysis undertaken by the Royal Oldham hospital.

Key facts
Reduction in administrative support
One hundred percent of all inpatient respiratory referrals can be managed without admin support freeing time to focus on other tasks.

Response times
Benchmarking for respiratory inpatient referrals showed that the existing process took on average 2.1 days before the receiving team got to review the referrals.

With the introduction of Bleepa and the removal of the manual administrative steps, referrals are actioned within 0.4 days. This represents a saving of 1.7 days per referral.

Releasing time to care
A benchmarking audit shows that the process of responding to referrers can take on average 7.5 minutes per referral. The introduction of Bleepa reduces this response time to less than one minute by enabling a receiving doctor to respond using the chat in Bleepa. This results in a clinical time saving of approximately 6.5 minutes per referral.

This equates to 5.6 weeks of a full-time clinician’s time released per annum based on current usage and a prediction of 36.3 weeks of clinical time per annum released if the project is expanded to all other medical teams.

[yump] 01/10/2021 08:01

Appears to be more significant than the previous general digital framework inclusion, as it specifically mentions imaging.

Amazing its taken so long for initial digital investment funding to be taken out of the silo budgeting environment.

Would be great to put that point to one of the senior managers in the NHS.